Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
Ware
G J
GJ
Department of Pharmacology, University of Auckland School of Medicine.
Ford
D J
DJ
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004363:Drug Utilization / Q000191:economics*; D006801:Humans; D007262:Infusions, Intravenous; D008485:Medical Audit / Q000191:economics*; D009520:New Zealand; D016134:Organizational Policy; D010607:Pharmacy Service, Hospital / Q000191:economics* / Q000458:organization & administration; D014600:Utilization Review / Q000191:economics
D000900:Anti-Bacterial Agents